Our study reveals that HIV-associated lymphomas display distinct molecular and clinicopathologic characteristics, including a high rate of EBV infection, a predominant GCB phenotype, and a paradoxical profile of high proliferative activity coupled with low BCL2 expression. Here, BCL2 is linked to lymphoma.